Friends Or Foes? The Changing Regulator/Industry Relationship In Europe
Executive Summary
Top leaders discuss the evolving concept of transparency, more proactive risk management, and industry/regulator interactions at a conference marking 50 years of the EU pharmaceutical legislation.
You may also be interested in...
New EFPIA Head Sought As Bergström Decides To Seek Fresh Pastures
The Swedish head of the European Federation of Pharmaceutical Industries and Associations is moving on after five years as EFPIA director general, but will stay at the helm to help find his successor.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.